|
|
|
|
|
Analysis of the mortality risk in septic shock patients with myocardial depression |
Wu Ding-ye, Gao Song, Heng Jun-feng, Yan Jie |
Intensive Care Unit, Wuxi People′s Hospital Affiliated to Nanjing Medical University, Wuxi 214023, China |
|
|
Abstract Objective The purpose of this study was to analyze the death risk in septic shock patients with myocardial depression. Methods Patients with septic shock in our ICU were recruited during the year 2015 and 2016. Patients with EF< 50% were recruited to myocardial depression group, and the others were recruited to non-myocardial depression group. The differences of CRP, PCT, Lac which obtained within 6 hours of hospitalization between two groups were analyzed. The differences of CRP, PCT, Lac, BNP, cTnI, SOFA score, average dose of norepinephrine obtained within 24~48 hours of hospitalization between two groups were analyzed. Multivariate Cox regression analysis was used to analyze the death risk of septic shock patients and its difference between two groups. Results 132 patients were recruited in the study. Patients′ 24~48 h Lac, BNP, cTnI, SOFA scores and the average dosage of norepinephrineof the myocardial depression group were higher than those of the non-myocardial depression group, and the difference was statistically significant(P<0.05). Multivariate Cox risk regression analysis showed that 24~48 h Lac, BNP, cTnI, SOFA score, average dose of norepinephrine and myocardial depression were risk factors for death in septic shock patients, and the difference was statistically significant(P<0.05). 14 days′ death risk of the patients in the myocardial depression group was 95.2% significantly higher than that in the non-myocardial depression group(P<0.05). The Annual risk of death was analyzed in patients who were still alive after 14 days′hospitalization, and the difference between two groups was not statistically significant. Conclusion The 14 days′ mortality risk factors of septic shock patients are 24~48 h Lac, BNP, cTnI, SOFA, the average dose of norepinephrine, and myocardial depression. The risk of death for 14 days in patients with myocardial depression is increased by 95.2%. There is no difference in annual mortality risk between the patients who are still alive after 14 days′ hospitalization in two groups.
|
|
Corresponding Authors:
Jie Yan, E-mail: yjeast@163.com
|
|
|
|
[1]Esper AM, Martin GS. Extending international sepsis epidemiology: the impact of organ dysfunction[J]. Crit Care, 2009, 13(1): 120.
[2]中华医学会重症医学分会. 中国严重脓毒症/脓毒性休克治疗指南(2014)[J]. 全科医学临床与教育, 2015, 13(4): 365-367.
[3]Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016[J]. Intensive Care Med, 2017, 43(3): 304-377.
[4]Antonucci E, Fiaccadori E, Donadello K, et al. Myocardial depression in sepsis: from pathogenesis to clinical manifestations and treatment[J]. J Crit Care, 2014, 29(4): 500-511.
[5]Elkins RC, McCurdy JR, Brown PP, et al. Effects of coronary perfusion pressure on myocardial performance during endotoxin shock[J]. Surg Gynecol Obstet, 1973, 137(6): 991-996.
[6]Cunnion RE, Schaer GL, Parker MM, et al. The coronary circulation in human septic shock[J]. Circulation, 1986, 73(4): 637-644.
[7]Groeneveld AB, van Lambalgen AA, van den Bos GC, et al. Maldistribution of heterogeneous coronary blood flow during canine endotoxin shock[J]. Cardiovasc Res, 1991, 25(1): 80-88.
[8]Reilly JM, Cunnion RE, Burch-Whitman C, et al. A circulating myocardial depressant substance is associated with cardiac dysfunction and peripheral hypoperfusion (Lactic acidemia) in patients with septic shock[J]. Chest, 1989, 95(5): 1072-1080.
[9]陶飞, 邓烈华, 姚华国. 脓毒症患者心功能障碍的发病机制[J]. 医学综述, 2012, 18(4): 538-541.
[10]Chopra M, Sharma AC. Distinct cardiodynamic and molecular characteristics during early and late stages of sepsis-induced myocardial dysfunction[J]. Life Sci, 2007, 81(4): 306-316.
[11]Stengl M, Bartak F, Sykora R, et al. Reduced L-type calcium current in ventricular myocytes from pigs with hyperdynamic septic shock[J]. Crit Care Med, 2010, 38(2): 579-587.
[12]Geoghegan-Morphet N, Burger D, Lu X, et al. Role of neuronal nitric oxide synthase in lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal mouse cardiomyocytes[J]. Cardiovasc Res, 2007, 75(2): 408-416.
[13]刘安雷, 刘洁, 于莺, 等. 脓毒症心功能障碍研究进展[J]. 中国急救医学, 2011, 31(9): 847-850.
[14]Parker MM, Shelhamer JH, Bacharach SL, et al. Profound but reversible myocardial depression in patients with septic shock[J]. Ann Intern Med, 1984, 100(4): 483-490.
[15]Vallabhajosyula S, Pruthi S, Shah S, et al. Basic and advanced echocardiographic evaluation of myocardial dysfunction in sepsis and septic shock[J]. Anaesth Intensive Care, 2018, 46(1): 13-24.
[16]Antonucci E, Agosta S. Speckle tracking echocardiography: another step towards early detection of septic myocardial dysfunction[J]. Crit Care, 2016, 20(1): 236.
[17]王睿, 臧彬. 脉波指示连续心排量监测对脓毒症合并重度心功能不全患者预后的影响[J]. 中国医学工程, 2013, 21(10): 8-9.
[18]陈德珠, 刘长智, 卢剑海, 等. 肌钙蛋白I、B型脑钠肽对脓毒症性心肌功能障碍发生的预测与预后评估价值[J]. 中华临床医师杂志(电子版), 2015, 9(12): 2286-2289.
[19]Sato R, Kuriyama A, Takada T, et al. Prevalence and risk factors of sepsis-induced cardiomyopathy: A retrospective cohort study[J]. Medicine (Baltimore), 2016, 95(39): e5031.
[20]Frencken JF, Donker DW, Spitoni C, et al. Myocardial Injury in Patients With Sepsis and Its Association With Long-Term Outcome[J]. Circ Cardiovasc Qual Outcomes, 2018, 11(2): e004 040. |
|
|
|